Shuyuan Yeh

13PUBLICATIONS
6CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 21, 2025
Correction: Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.

Bosen You, Yin Sun, Jie Luo

|Apr 18, 2023
The androgen receptor in bladder cancer.

Jinbo Chen, Chi-Ping Huang, Chao Quan

|Aug 01, 2022
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling.

Qing Liu, Bosen You, Jialin Meng

|Jun 07, 2022
Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.

Yang Yang, Jindong Sheng, Shuai Hu

|Jun 15, 2021
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.

Gang Deng, Ronghao Wang, Yin Sun

|Jan 29, 2021
Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.

Bosen You, Yin Sun, Jie Luo

Pageof 3

Frequent Collaborators

7 joint publications

Chawnshang Chang

3 joint publications

Wanhai Xu

2 joint publications

Jialin Meng

2 joint publications

Chi-Ping Huang